ConductScience.org, home

Paper41512959

Accelerating cancer treatment optimisation: A multistakeholder roadmap from the Cancer Medicines Forum.

Lacombe D and 18 others. J Cancer Policy, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Accelerating cancer treatment optimisation: A multistakeholder roadmap from the Cancer Medicines Forum. Papers, record 41512959. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41512959

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Accelerating cancer treatment optimisation: A multistakeholder roadmap from the Cancer Medicines Forum.
PubMed
Journal
J Cancer Policy
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors19

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lacombe DDenis
2Cardoso Borges FFábio
3Amariutei AEAna E
4Booth CMChristopher M
5Brusselle GGuy
6Casolino RRaffaella
7Demolis PPierre
8Giuliani RRosa
9Goldstein DADaniel A
10Gravis GGwenaelle
11Kaiser MMartin
12Korakis IIphigenie
13Radulovic MMomir
14Sullivan RRichard
15Tombal BBertrand
16Wieseler BBeate
17Zaiac MMichael
18Voltz-Girolt CCaroline
19Pignatti FFrancesco

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Antineoplastic AgentsMajor topic
Humans
Quality of Life
European Union

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
001World Health OrganizationInternationalPubMed

Source PubMed

Download CSV of grants

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138779087EORTC 2238 "De-Escalate": a pragmatic trial to revisit intermittent androgen deprivation therapy in the era of new androgen receptor pathway inhibitors.Front Oncol2024https://conductscience.org/library/papers/38779087PubMed
240553420Discontinuation of Immune Checkpoint Inhibition in Patients with Advanced Unresectable Melanoma Achieving CR, PR, or SD.Target Oncol2025https://conductscience.org/library/papers/40553420PubMed
332936713Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients.J Clin Oncol2020https://conductscience.org/library/papers/32936713PubMed
429565196Developing an instrument to assess patient preferences for benefits and risks of treating acute myeloid leukemia to promote patient-focused drug development.Curr Med Res Opin2018https://conductscience.org/library/papers/29565196PubMed
538081195The need for pragmatic, affordable, and practice-changing real-life clinical trials in oncology.Lancet2024https://conductscience.org/library/papers/38081195PubMed
635205637Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 Years.Cancers (Basel)2022https://conductscience.org/library/papers/35205637PubMed
733746750What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient Preferences.Front Pharmacol2021https://conductscience.org/library/papers/33746750PubMed
833764385Evolution of the Randomized Clinical Trial in the Era of Precision Oncology.JAMA Oncol2021https://conductscience.org/library/papers/33764385PubMed
930999145Establishing treatment optimisation as part of personalised medicine development.Eur J Cancer2019https://conductscience.org/library/papers/30999145PubMed
1038263138Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9-Pragmatic Research and Innovation through Multinational Experimentation.Trials2024https://conductscience.org/library/papers/38263138PubMed
1136400101European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology Commission.Lancet Oncol2023https://conductscience.org/library/papers/36400101PubMed
1240318657Defining the role of pragmatic clinical trials in cancer clinical research: outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of Cancer.Lancet Oncol2025https://conductscience.org/library/papers/40318657PubMed
1338492274Elements of successful patient involvement in clinical cancer trials: a review of the literature.ESMO Open2024https://conductscience.org/library/papers/38492274PubMed
1432116718Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making.Front Pharmacol2020https://conductscience.org/library/papers/32116718PubMed
1528987771
'Mind the gap' between the development of therapeutic innovations and the clinical practice in oncology: A proposal of the European Organisation for Research and Treatment of Cancer (EORTC) to optimise cancer clinical research.
Eur J Cancer2017https://conductscience.org/library/papers/28987771PubMed
1627595308Publicly funded practice-oriented clinical trials: of importance for healthcare payers.J Comp Eff Res2016https://conductscience.org/library/papers/27595308PubMed
1736109818Identifying obstacles hindering the conduct of academic-sponsored trials for drug repurposing on rare-diseases: an analysis of six use cases.Trials2022https://conductscience.org/library/papers/36109818PubMed
1839844438Experiences with low-intervention clinical trials-the new category under the European Union Clinical Trials Regulation.Clin Trials2025https://conductscience.org/library/papers/39844438PubMed
1939271845Post-approval evidence generation: a shared responsibility for healthcare.Nat Med2024https://conductscience.org/library/papers/39271845PubMed
2034623789The Drug-Dosing Conundrum in Oncology - When Less Is More.N Engl J Med2021https://conductscience.org/library/papers/34623789PubMed

See all 30 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41512959

GET https://conductscience.org/api/papers/v1/41512959/references?page=2